Aim: Few studies have evaluated patients after cardiac surgery for subsequent chronic kidney disease (CKD) which increases cardiovascular morbidity and mortality. This study aimed to ascertain the long-term renal outcome in adult patients with severe acute kidney injury (AKI) after coronary artery bypass graft (CABG) surgery. Methods: This is a single-center retrospective cohort study of consecutive adult patients who received acute dialysis for AKI after CABG between February 8, 2009 and January 30, 2011. Data on pre- and intra-operative factors were retrieved from electronic medical records. The primary endpoint was CKD progression as defined by dialysis dependence or doubling of serum creatinine from the pre-operative level. Secondary endpoints included in-hospital mortality and renal function at 3 months and 1 year. Results: Fifty-five patients required acute dialysis after CABG. The median age was 67 years (IQR: 61, 75), and 70.9% were male. Median pre-operative serum creatinine was 157 µmol/l (IQR: 122, 203). A total of 19 patients (34.5%) died. The median follow-up time for hospital survivors was 44.2 months (IQR: 25.0, 49.4) after surgery. Among the 36 survivors, 14 patients (38.9%) reached the primary endpoint. Patients with CKD progression had higher pre-operative serum creatinine [median 214 µmol/l (IQR: 159, 399) vs. 155 µmol/l (112, 187), p = 0.015] and lower eGFR [median 20.4 ml/min/1.73 m2 (IQR: 11.9, 38.2) vs. 39.9 ml/min/1.73 m2 (25.9, 55.5), p = 0.027] compared to those who did not have CKD progression. Conclusion: Patients with severe AKI after CABG are at high risk of long-term renal dysfunction and should be monitored regularly for deterioration.

Keywords:
Acute kidney injury, Renal replacement therapy, Intensive care, Coronary artery bypass, Kidney failure, Chronic kidney disease
1.
Nowbar AN, Howard JP, Finegold JA, et al: 2014 Global geographic analysis of mortality from ischaemic heart disease by country, age and income: statistics from World Health Organisation and United Nations. Int J Cardiol 2014;174:293-298.
2.
Deb S, Wijeysundera HC, Ko DT, et al: Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review. JAMA 2013;310:2086-2095.
3.
Englberger L, Suri RM, Li Z, et al: Clinical accuracy of RIFLE and Acute Kidney Injury Network (AKIN) criteria for acute kidney injury in patients undergoing cardiac surgery. Crit Care 2011;15:R16.
4.
Goldberg R, Dennen P: Long-term outcomes of acute kidney injury. Adv Chronic Kidney Dis 2008;15:297-307.
5.
McIlroy DR, Argenziano M, Farkas D, et al: Incorporating oliguria into the diagnostic criteria for acute kidney injury after on-pump cardiac surgery: impact on incidence and outcomes. J Cardiothorac Vasc Anesth 2013;27:1145-1152.
6.
Hansen MK, Gammelager H, Mikkelsen MM, et al: Post-operative acute kidney injury and five-year risk of death, myocardial infarction, and stroke among elective cardiac surgical patients: a cohort study. Crit Care 2013;17:R292.
7.
Pickering JW, James MT, Palmer SC: Acute kidney injury and prognosis after cardiopulmonary bypass: a meta-analysis of cohort studies. Am J Kidney Dis 2015;65:283-293.
8.
Swaminathan M, Hudson CC, Phillips-Bute BG, et al: Impact of early renal recovery on survival after cardiac surgery-associated acute kidney injury. Ann Thorac Surg 2010;89:1098-1104.
9.
Karkouti K, Wijeysundera DN, Yau TM, et al: Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation 2009;119:495-502.
10.
Leacche M, Winkelmayer WC, Paul S, et al: Predicting survival in patients requiring renal replacement therapy after cardiac surgery. Ann Thorac Surg 2006;81:1385-1392.
11.
Lopez-Delgado JC, Esteve F, Torrado H, et al: Influence of acute kidney injury on short- and long-term outcomes in patients undergoing cardiac surgery: risk factors and prognostic value of a modified RIFLE classification. Crit Care 2013;17:R293.
12.
Hobson CE, Yavas S, Segal MS, et al: Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation 2009;119:2444-2453.
13.
Li SY, Chen JY, Yang WC, et al: Acute kidney injury network classification predicts in-hospital and long-term mortality in patients undergoing elective coronary artery bypass grafting surgery. Eur J Cardiothorac Surg 2011;39:323-328.
14.
Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32(suppl 3):S112-S119.
15.
McClellan WM, Anson C, Birkeli K, et al: Functional status and quality of life: predictors of early mortality among patients entering treatment for end stage renal disease. J Clin Epidemiol 1991;44:83-89.
16.
Roques F, Michel P, Goldstone AR, et al: The logistic EuroSCORE. Eur Heart J 2003;24:881-882.
17.
Levey AS, Stevens LA, Schmid CH, et al: A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-612.
18.
Teo BW, Xu H, Koh YY, et al: Estimating kidney function in a multiethnic Asian population with multiple filtration markers. Am J Kidney Dis 2012;60:500-502.
19.
Bagshaw SM, Uchino S, Bellomo R, et al: Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury. J Crit Care 2009;24:129-140.
20.
Mehta RL, Kellum JA, Shah SV, et al: Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11:R31.
21.
Rosner MH, Okusa MD: Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol 2006;1:19-32.
22.
Srivastava V, D'Silva C, Tang A, et al: The impact of major perioperative renal insult on long-term renal function and survival after cardiac surgery. Interact Cardiovasc Thorac Surg 2012;15:14-17.
23.
Luckraz H, Gravenor MB, George R, et al: Long and short-term outcomes in patients requiring continuous renal replacement therapy post cardiopulmonary bypass. Eur J Cardiothorac Surg 2005;27:906-909.
24.
Ishani A, Nelson D, Clothier B, et al: The magnitude of acute serum creatinine increase after cardiac surgery and the risk of chronic kidney disease, progression of kidney disease, and death. Arch Intern Med 2011;171:226-233.
25.
Ryden L, Sartipy U, Evans M, et al: Acute kidney injury after coronary artery bypass grafting and long-term risk of end-stage renal disease. Circulation 2014;130:2005-2011.
26.
Garcia-Fernandez N, Perez-Valdivieso JR, Bes-Rastrollo M, et al: Timing of renal replacement therapy after cardiac surgery: a retrospective multicenter Spanish cohort study. Blood Purif 2011;32:104-111.
27.
Shum HP, Chan KC, Kwan MC, et al: Timing for initiation of continuous renal replacement therapy in patients with septic shock and acute kidney injury. Ther Apher Dial 2013;17:305-310.
28.
Chou YH, Huang TM, Wu VC, et al: Impact of timing of renal replacement therapy initiation on outcome of septic acute kidney injury. Crit Care 2011;15:R134.
29.
Doi K, Yuen PS, Eisner C, et al: Reduced production of creatinine limits its use as marker of kidney injury in sepsis. J Am Soc Nephrol 2009;20:1217-1221.
30.
Go AS, Parikh CR, Ikizler TA, et al: The assessment, serial evaluation, and subsequent sequelae of acute kidney injury (ASSESS-AKI) study: design and methods. BMC Nephrol 2010;11:22.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.